Jakub Závada (J Závada, Jakub Zavada)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Ankylosing Spondylitis

Radical Prostatectomy

Monoclonal Antibody

Top Venues

The Journal of rheumatology

Rheumatology international

Arthritis research & therapy

Scandinavian journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Š Tichý, Lucie Nekvindová, J Baranová, Jiri Vencovsky, Karel Pavelka, Pavel Horak, Jakub Závada
Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry. Scandinavian journal of rheumatology (2024)
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Sella Aarrestad Provan, Eirik Klami Kristianslund, Ana Maria Rodrigues, Maria Jose Santos, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Gary John Macfarlane, Gareth T Jones, Irene E van der Horst-Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? The Journal of rheumatology 51 (7) (2024)
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Sella Aarrestad Provan, Eirik Klami Kristianslund, Ana Maria Rodrigues, Maria Jose Santos, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Gary John Macfarlane, Gareth T Jones, Irene E van der Horst-Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? The Journal of rheumatology (2024)
Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen M Fagerli, Jiri Vencovsky, Maria Jose Santos, Burkhard Möller, Manuel Pombo-Suarez, Žiga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth T Jones, Marleen G H van de Sande, Johan Karlsson Wallman, Marco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sánchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology 51 (4) (2024)
Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K Kvien, Daniela di Giuseppe, Johan Karlsson Wallman, Jakub Závada, Sella Aarrestad Provan, Eirik Klami Kristianslund, Ana Maria Rodrigues, Maria Jose Santos, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Gary John Macfarlane, Gareth T Jones, Irene E van der Horst-Bruinsma, Pasoon Hellamand, Mikkel Østergaard, Merete Lund Hetland
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? The Journal of rheumatology 51 (7) (2024)
Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Karen M Fagerli, Jiri Vencovsky, Maria Jose Santos, Burkhard Möller, Manuel Pombo-Suarez, Žiga Rotar, Bjorn Gudbjornsson, Ayse Cefle, Kari Eklund, Catalin Codreanu, Gareth T Jones, Marleen G H van de Sande, Johan Karlsson Wallman, Marco Sebastiani, Brigitte Michelsen, Jakub Závada, Michael John Nissen, Carlos Sánchez-Piedra, Matija Tomšič, Thorvardur Jon Love, Heikki Relas, Corina Mogosan, Merete Lund Hetland, Mikkel Østergaard
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care. The Journal of rheumatology 51 (4) (2024)
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F Van Vollenhoven, Rosemary J Hollick, Ovidiu Rotariu, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Anna-Mari Hokkanen, Brigitte Michelsen, Tore K Kvien, Bente Glintborg, Merete Lund Hetland, Mikkel Østergaard, Anne Gitte Loft, Karel Pavelka, Jakub Závada, Isabel Castrejon, Lucia Otero Varela, Bjorn Gudbjornsson, Olafur Palsson, Tor Olofsson, Johan Karlsson Wallman, Adrian Ciurea, Michael John Nissen, Tuba D Yildirim, Fatoş Önen, Catalin Codreanu, Corina Mogosan, Maria Jose Santos, Elsa Viera Sousa, Florenzo Iannone, Bruno Frediani, Lykke Midtbøll Ørnbjerg, Jos W R Twisk, Irene E van der Horst-Bruinsma
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors. Rheumatology (Oxford, England) (2024)
Aleš Kvasnička, David Friedecký, Radana Brumarová, Markéta Pavlíková, Kateřina Pavelcová, Jana Mašínová, Lenka Hasikova, Jakub Závada, Karel Pavelka, Pavel Ješina, Blanka Stibůrková
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment. Arthritis research & therapy 25 (1) (2023)
Lucie Nekvindová, Jiří Vencovský, Karel Pavelka, Pavel Horák, Zlatuše Křístková, Jakub Závada
Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry. Arthritis research & therapy 23 (1) (2021)
Jan Tuzil, Tomas Mlcoch, Jitka Jirčíková, Jakub Závada, Lucie Nekvindová, Michal Svoboda, Michal Uher, Zlatuše Křístková, Jiri Vencovsky, Karel Pavelka, Tomáš Doležal
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry. Expert opinion on biological therapy 20 (2) (2019)
Lenka Hasikova, Markéta Pavlíková, Hana Hulejová, Petr Kozlík, Kveta Kalikova, Aparna Mahajan, Martin Herrmann, Blanka Stibůrková, Jakub Závada
Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors. Rheumatology international 39 (10) (2019)
Valentina Prevolnik Rupel, Marko Divjak, Zsombor Zrubka, Fanni Rencz, László Gulácsi, Dominik Golicki, Dagmara M Mirowska-Guzel, Judit Simon, Valentin Brodszky, Petra Baji, Jakub Závada, Guenka Petrova, Alexandru M Rotar, Márta Péntek
EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review. The European journal of health economics : HEPAC : health economics in prevention and care 20 (Suppl 1) (2019)
Anne Lee, Marianne Sandvei, Hans Christian Asmussen, Marie Skougaard, Joanne Macdonald, Jakub Závada, Henning Bliddal, Peter C Taylor, Henrik Gudbergsen
The Development of Complex Digital Health Solutions: Formative Evaluation Combining Different Methodologies. JMIR research protocols 7 (7) (2018)
Barbora Šumová, Lucie Andrés Cerezo, Lenka Szczuková, Lucie Nekvindová, Michal Uher, Hana Hulejová, Radka Moravcová, Mariam Grigorian, Karel Pavelka, Jiri Vencovsky, Ladislav Senolt, Jakub Závada
Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatology international 39 (3) (2018)